- Home
- AARD vs AIRT Comparison
AARD vs AIRT Comparison
Compare AARD & AIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AARD | AIRT |
|---|---|---|
| Founded | 2017 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.4M | 87.8M |
| IPO Year | 2025 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AARD | AIRT |
|---|---|---|
| Price | $1.50 | $25.91 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $11.11 | N/A |
| AVG Volume (30 Days) | ★ 108.4K | 30.8K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.11 | ★ 1393.72 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $286,834,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.98 |
| 52 Week Low | $3.35 | $18.35 |
| 52 Week High | $16.60 | $35.00 |
Technical Indicators
Market Signals| Indicator | AARD | AIRT |
|---|---|---|
| Relative Strength Index (RSI) | 20.61 | 32.45 |
| Support Level | N/A | $20.67 |
| Resistance Level | $5.88 | $34.30 |
| Average True Range (ATR) | 0.55 | 1.44 |
| MACD | -0.17 | -0.46 |
| Stochastic Oscillator | 1.00 | 8.39 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include overnight air cargo, ground support equipment, commercial aircraft, engines and parts, digital solutions, and regional airline. The company generates maximum revenue from the overnight air cargo segment.